Cleared Traditional

Epi-Stop Nasal Gel/epistaxis pack

K230142 · Biomed Ent, Inc. · Ear, Nose, Throat
Mar 2023
Decision
63d
Days
Class 1
Risk

About This 510(k) Submission

K230142 is an FDA 510(k) clearance for the Epi-Stop Nasal Gel/epistaxis pack, a Splint, Intranasal Septal (Class I — General Controls, product code LYA), submitted by Biomed Ent, Inc. (San Antonio, US). The FDA issued a Cleared decision on March 22, 2023, 63 days after receiving the submission on January 18, 2023. This device falls under the Ear, Nose, Throat review panel. Regulated under 21 CFR 874.4780.

Submission Details

510(k) Number K230142 FDA.gov
FDA Decision Cleared SESE
Date Received January 18, 2023
Decision Date March 22, 2023
Days to Decision 63 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code LYA — Splint, Intranasal Septal
Device Class Class I — General Controls
CFR Regulation 21 CFR 874.4780